U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07120620) titled 'PriCoTTF Study: TTFields Before and During Radiotherapy for Newly Diagnosed Glioblastoma' on June 16.
Brief Summary: The PriCoTTF clinical trial is related to the development and validation of the investigational product Optune(R), a device for generating tumor therapy fields (TTFields) that is used in combination with radiation therapy to treat newly diagnosed glioblastoma. The trial aims to evaluate the safety of early and concurrent use of TTFields with standard radiation chemotherapy. This strategy is based on preclinical data suggesting that TTFields increase the sensitivity of tumor cells to radiation therapy. Critical compone...